Important link between dementia subtype and apolipoprotein E: a meta-analysis

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Apolipoprotein E (apoE) genotype is a known genetic factor associated with dementia risk.
• Previous studies suggest a link between the apoE ε4 allele and Alzheimer's disease (AD).
• The role of apoE genotype in differentiating various dementia subtypes remains less clear.

Purpose of the Study:

• To evaluate the differential diagnostic role of apolipoprotein E (apoE) genotype in various dementia types.
• To analyze apoE allele frequencies and genotype-specific odds ratios (OR) across dementia subgroups.
• To determine if apoE genotype risk varies significantly among subtypes of Alzheimer's disease and non-Alzheimer's dementias.

Main Methods:

• Conducted a meta-analysis of 78 case-control series, including new data.
• Grouped dementia subjects into Alzheimer's disease (AD) and non-AD categories.
• Subgrouped AD patients by subtype and non-AD patients into vascular dementia (VD), mixed dementia (MD), and non-AD non-VD dementia (NAVD).

Main Results:

• The apoE ε4 allele frequency was higher in all dementia subgroups compared to controls.
• Associations with apoE ε4 were lower in non-AD (OR 1.8) than in AD (OR 4.2) patients.
• ApoE-related risk varied significantly by subtype: AD (OR 2.3–11.3), MD (OR 2.6), VD (OR 1.3), NAVD (OR 1.9), and Lewy body dementia (LBD) (OR 5.1).

Conclusions:

• Variability in apoE-related risk exists within both AD and non-AD dementia cases, dependent on specific subtypes.
• Precise subgrouping of AD and non-AD patients is essential for accurate interpretation of apoE genotyping results.
• ApoE genotyping may serve as a differential diagnostic tool when considering dementia subtypes, particularly LBD.